Iberdomide vs. Observation Post Ide-Cel CAR-T
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Near Add Your Location
Sorting 73 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Accepting patients
Memorial Sloan Kettering Commack
Commack, NY
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Westchester
West Harrison, NY
- Accepting patients
- Show Principal Investigator
- Accepting patients
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Accepting patients
University of Illinois at Chicago
Chicago, IL
- Not currently accepting
- Not yet accepting
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.